Home Page
About us
Guangzhou KOFA Biotechnology Co., Ltd. is a national high-tech enterprise specializing in the R&D, manufacturing, sales, and service of in vitro diagnostic (IVD) reagents and instruments. Founded in 2004 and headquartered in the Sino-Singapore Knowledge City, Guangzhou, the company has built its growth on a strategy of independent intellectual property, independent innovation, and independent branding.
KOFA has established four core technology platforms: biochemical immunoassay assembly line, chemiluminescence detection, fluorescent immunochromatography, and biochemical diagnostics. These platforms support a broad portfolio of more than 200 registered products, covering clinical areas including liver and kidney function, cardiovascular disease, blood lipids, diabetes, genetic disorders, tumors, and thyroid function.
Our products are widely adopted by medical institutions and third-party testing centers across China, serving as a trusted partner for clinical diagnostics at every level of care.
News Center
Compared with traditional IVD products, POCT has three major advantages: short test time, wide detection space, and easy operation. It can meet the needs of fast and timely testing, and has become a revolutionary and rapidly developing sub field in the IV
More+
Products
Service Support
KOFA has always upheld the philosophy of “Technology Benefiting All” and has remained steadfast in its commitment to delivering high-quality products and exceptional technical services to customers over the years. Backed by a strong technical support team, we provide professional product consultation, reagent optimization, and comprehensive after-sales services to promptly address any technical issues our customers may encounter during product use.
Contact us
2025-06-17 Kefang News
April 15 to 21, 2025 is the 31st National Cancer Prevention and Treatment Publicity Week. The theme of the 2025 Publicity Week is "Scientific Cancer Prevention and Healthy Life". It aims to popularize scientific knowledge on cancer prevention and treatment, advocate the public to practice a healthy lifestyle, control cancer risk factors; encourage high-risk groups to actively participate in cancer screening, promote early diagnosis and treatment; guide cancer patients to receive standardized diagnosis and treatment in a timely manner, and have regular follow-up examinations. Through the whole process and life cycle health management, better meet the health needs of the people and ensure their healthy life.